Risk of Selecting De Novo Drug-Resistance Mutations during Structured Treatment Interruptions in Patients with Chronic HIV Infection

This publication has 24 references indexed in Scilit:

• Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection
  The Journal of Infectious Diseases, 2005
• Treatment for Adult HIV Infection
  JAMA, 2004
• Emergence of Minor Populations of Human Immunodeficiency Virus Type 1 Carrying the M184V and L90M Mutations in Subjects Undergoing Structured Treatment Interruptions
  The Journal of Infectious Diseases, 2003
• Lack of persistent drug-resistant mutations evaluated within and between treatment interruptions in chronically HIV-1-infected patients
  AIDS, 2003
• Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus
  New England Journal of Medicine, 2003
• Long‐Cycle Structured Intermittent versus Continuous Highly Active Antiretroviral Therapy for the Treatment of Chronic Infection with Human Immunodeficiency Virus: Effects on Drug Toxicity and on Immunologic and Virologic Parameters
  The Journal of Infectious Diseases, 2003
• A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions
  AIDS, 2003
• Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV
  AIDS, 2003
• Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia
  New England Journal of Medicine, 2001
• Transient Mobilization of Human Immunodeficiency Virus (HIV)-Specific CD4 T-Helper Cells Fails To Control Virus Rebounds during Intermittent Antiretroviral Therapy in Chronic HIV Type 1 Infection
  Journal of Virology, 2001